We are live on ! Find out more
IRD

Opus Genetics
IRD

36 hedge funds and large institutions have $7.15M invested in Opus Genetics in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more capital invested

Capital invested by funds: $3.21M → $7.15M (+$3.94M)

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

6% more funds holding

Funds holding: 34 → 36 (+2)

Holders
36
Holders Change
+2
Holders Change %
+5.88%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$4.58M
2
Renaissance Technologies
Renaissance Technologies
New York
+$145K
3
CCM
Condor Capital Management
New Jersey
+$50.3K
4
AT
Arden Trust
Delaware
+$17.3K
5
GC
Guggenheim Capital
Illinois
+$13K

Top Sellers

Rank Fund Capital Flow
1
SBIA
Sheaff Brock Investment Advisors
Indiana
-$25K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$15.1K
3
Creative Planning
Creative Planning
Kansas
-$9.82K
4
TSS
Two Sigma Securities
New York
-$7.32K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$4.36M +$4.58M +27,526 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.6M -$15.1K -91 -0.9%
Renaissance Technologies
3
Renaissance Technologies
New York
$556K +$145K +874 +33%
BIT
4
BlackRock Institutional Trust
California
$110K – – –
Northern Trust
5
Northern Trust
Illinois
$70K – – –
HVIA
6
Hudson Valley Investment Advisors
New York
$66K – – –
VKH
7
Virtu KCG Holdings
New York
$53K +$5.83K +35 +12%
NFC
8
Northeast Financial Consultants
Connecticut
$50K – – –
Bank of New York Mellon
9
Bank of New York Mellon
New York
$48K – – –
CCM
10
Condor Capital Management
New Jersey
$48K +$50.3K +302 New
BMC
11
Benin Management Corp
Connecticut
$27K – – –
GC
12
Guggenheim Capital
Illinois
$23K +$13K +78 +118%
AT
13
Arden Trust
Delaware
$17K +$17.3K +104 New
Goldman Sachs
14
Goldman Sachs
New York
$16K +$2.83K +17 +20%
BA
15
BlackRock Advisors
Delaware
$15K – – –
State Street
16
State Street
Massachusetts
$14K – – –
BFA
17
BlackRock Fund Advisors
California
$12K +$2.5K +15 +25%
Cambridge Investment Research Advisors
18
Cambridge Investment Research Advisors
Iowa
$11K – – –
ASN
19
Advisory Services Network
Georgia
$8K – – –
Millennium Management
20
Millennium Management
New York
$8K +$8.82K +53 New
FHC
21
First Heartland Consultants
Missouri
$7K – – –
TSS
22
Two Sigma Securities
New York
$5K -$7.32K -44 -59%
ICOA
23
Investment Centers of America
North Dakota
$3K – – –
NPT
24
Nixon Peabody Trust
Massachusetts
$3K – – –
UBS Group
25
UBS Group
Switzerland
$3K – – –
1
2

IRD Hedge Fund Activity: Q1 2016 in Review

36 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q1 2016, worth a combined $7.15M — up 123% from $3.21M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new IRD positions and 4 closed out — a net gain of 2 holders — while 7 added to existing stakes and 5 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $4.58M. The largest seller was Sheaff Brock Investment Advisors, exiting entirely with an estimated $25K sold.

  • 36 institutional investors held Opus Genetics (IRD) as of Q1 2016, up from 34 in Q4 2015.
  • Funds reported $7.15M of Opus Genetics stock for Q1 2016, up 123% quarter-over-quarter.
  • 6 funds opened new Opus Genetics positions in Q1 2016 and 4 closed out, a net change of +2 holders.
  • The largest Opus Genetics buyer in Q1 2016 was Sabby Management, an estimated $4.58M added.
  • The largest Opus Genetics seller in Q1 2016 was Sheaff Brock Investment Advisors, an estimated $25K sold.

Based on aggregated 13F filings for Q1 2016.